|
Market Closed -
Australian S.E.
00:10:10 2026-11-09 EST
|
5-day change | 1st Jan Change | ||
| 0.4500 AUD | +1.12% |
|
+3.45% | +25.00% |
Company Valuation: Starpharma Holdings Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 302.2 | 36.8 | 294.6 | 213.5 | - | - |
| Change | - | - | 700.6% | -27.55% | - | - |
| Enterprise Value (EV) 1 | 302.2 | 36.8 | 283.6 | 186.2 | 175 | 129.6 |
| Change | - | - | 670.67% | -34.34% | -6.06% | -25.93% |
| P/E | -18.5x | -4.4x | -35x | -14.8x | 98.9x | 9.08x |
| PBR | - | - | 21.4x | 4.05x | 3.18x | 2.23x |
| PEG | - | - | - | -0.3x | -1x | 0x |
| Capitalization / Revenue | - | - | 24.5x | 33.9x | 8.13x | 3.88x |
| EV / Revenue | - | - | 23.5x | 29.6x | 6.66x | 2.36x |
| EV / EBITDA | - | - | -39.5x | -12.8x | 60.7x | 4.52x |
| EV / EBIT | - | - | -38x | -12.6x | 67.6x | 4.56x |
| EV / FCF | - | - | -97x | -169x | 15.2x | 5.31x |
| FCF Yield | - | - | -1.03% | -0.59% | 6.57% | 18.8% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.04 | -0.02 | -0.02 | -0.03 | 0.0045 | 0.049 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | 12.05 | 6.3 | 26.25 | 55 |
| EBITDA 1 | - | - | -7.177 | -14.54 | 2.884 | 28.7 |
| EBIT 1 | - | - | -7.465 | -14.83 | 2.589 | 28.4 |
| Net income 1 | -16.15 | -9.99 | -7.465 | -16.25 | 1.707 | 25.6 |
| Net Debt 1 | - | - | -11.02 | -27.25 | -38.53 | -83.9 |
| Reference price 2 | 0.7400 | 0.0880 | 0.7000 | 0.4450 | 0.4450 | 0.4450 |
| Nbr of stocks (in thousands) | 408,443 | 418,225 | 420,928 | 479,739 | - | - |
| Announcement Date | 8/24/22 | 8/26/25 | 8/25/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.83x | 29.56x | -12.81x | - | 147M | |
| 39.62x | 13.42x | 28.51x | 0.5% | 1,206B | |
| 40.43x | 6.79x | 19.09x | 1.93% | 665B | |
| 37.52x | 8.51x | 17.57x | 2.38% | 515B | |
| 20.98x | 5.12x | 12.74x | 2.57% | 381B | |
| 104.15x | 5.94x | 25.33x | 2.32% | 362B | |
| 23.47x | 5.94x | 14.26x | 2.69% | 307B | |
| 24.46x | 4.89x | 13.77x | 1.79% | 289B | |
| 23.75x | 7.3x | 13.55x | 2.19% | 249B | |
| -39.18x | 7.27x | 45.77x | 1.98% | 207B | |
| Average | 26.04x | 9.47x | 17.78x | 2.04% | 417.99B | |
| Weighted average by Cap. | 36.30x | 8.55x | 21.85x | 1.73% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SPL Stock
- Valuation Starpharma Holdings Limited
Select your edition
All financial news and data tailored to specific country editions
